Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barata

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
The Oncologist|October 22, 2025
Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, et al.
Cancer|December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trialsGeorges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
Cancer|March 9, 2018
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNANeeraj Agarwal, Sumanta K Pal, Andrew W Hahn, et al.
Nature|July 1, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancerToni K Choueiri, Jamie Merchan, Amita Patnaik, et al.
JAMA Network Open|September 18, 2023
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate CancerClara Hwang, Nicholas C Henderson, Shih-Chun Chu, et al.
JCO Oncology Practice|May 2, 2025
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate CancerSigrid V Carlsson, Pedro C Barata, Alan H Bryce, et al.
JCO Precision Oncology|December 5, 2025
Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate CancerDeepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Prostate|November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessChanning J Paller, Pedro C Barata, Justin Lorentz, et al.
Cancer Treatment Reviews|May 21, 2019
Improving attribution of adverse events in oncology clinical trialsGoldy C George, Pedro C Barata, Alicyn Campbell, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
The Oncologist|October 22, 2025
Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, et al.
Cancer|December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trialsGeorges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
Cancer|March 9, 2018
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNANeeraj Agarwal, Sumanta K Pal, Andrew W Hahn, et al.
Nature|July 1, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancerToni K Choueiri, Jamie Merchan, Amita Patnaik, et al.
JAMA Network Open|September 18, 2023
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate CancerClara Hwang, Nicholas C Henderson, Shih-Chun Chu, et al.
JCO Oncology Practice|May 2, 2025
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate CancerSigrid V Carlsson, Pedro C Barata, Alan H Bryce, et al.
JCO Precision Oncology|December 5, 2025
Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate CancerDeepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Prostate|November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessChanning J Paller, Pedro C Barata, Justin Lorentz, et al.
Cancer Treatment Reviews|May 21, 2019
Improving attribution of adverse events in oncology clinical trialsGoldy C George, Pedro C Barata, Alicyn Campbell, et al.
Pageof 21